SetPoint Medical Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 90

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $115M

  • Investors
  • 29

SetPoint Medical General Information

Description

Developer of an implantable bioelectronic medical device designed to modulate neuroimmune pathways for reducing inflammation and restoring immunologic balance in chronic autoimmune conditions. The company delivers targeted electrical stimulation to the vagus nerve through a small, wireless implant programmed to provide daily therapy automatically with low maintenance, enabling healthcare providers and patients managing autoimmune diseases such as rheumatoid arthritis to access an alternative to traditional drug treatments with potentially reduced risk and treatment burden.

Contact Information

Formerly Known As
Innovative Metabolics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25101 Rye Canyon Loop
  • Valencia, CA 91355
  • United States
+1 (661)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 25101 Rye Canyon Loop
  • Valencia, CA 91355
  • United States
+1 (661)

SetPoint Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SetPoint Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC (Series D) 28-Oct-2025 $115M Completed Generating Revenue
15. General Corporate Purpose 19-Jan-2023 Completed Clinical Trials - Phase 2
14. Secondary Transaction - Private Completed Clinical Trials - Phase 2
13. Later Stage VC (Series C) 13-Jan-2023 Completed Clinical Trials - Phase 2
12. Secondary Transaction - Private 01-Jan-2023 Completed Clinical Trials - Phase 2
11. Mezzanine 29-Dec-2022 Completed Clinical Trials - General
10. Mezzanine 29-Jun-2021 Completed Clinical Trials - General
9. Later Stage VC (Series B) 09-Nov-2020 Completed Clinical Trials - General
8. Debt - PPP 13-Apr-2020 $1.1M $106M Completed Clinical Trials - General
7. Later Stage VC (Series A) 17-Sep-2019 $15.7M $106M Completed Clinical Trials - General
To view SetPoint Medical’s complete valuation and funding history, request access »

SetPoint Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 65,407,963 $0.001000 8% $1 $1 1x $1 20.55%
Series A 42,604,328 $0.001000 8% $1 $1 1x $1 13.38%
To view SetPoint Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SetPoint Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable bioelectronic medical device designed to modulate neuroimmune pathways for reducing inflamma
Therapeutic Devices
Valencia, CA
90 As of 2025

Eindhoven, Netherlands
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SetPoint Medical Competitors (13)

One of SetPoint Medical’s 13 competitors is Salvia BioElectronics, a Venture Capital-Backed company based in Eindhoven, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Salvia BioElectronics Venture Capital-Backed Eindhoven, Netherlands
Mainstay Medical Venture Capital-Backed San Diego, CA
Saluda Medical Formerly PE-Backed Bloomington, MN
Aleva Neurotherapeutics Private Equity-Backed Lausanne, Switzerland
Curonix Private Equity-Backed Pompano Beach, FL
You’re viewing 5 of 13 competitors. Get the full list »

SetPoint Medical Patents

SetPoint Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260124450-A1 Methods for treating bone erosion Pending 01-Nov-2024
WO-2026073166-A1 Treatment of senescence by vagus nerve stimulation Pending 27-Sep-2024
US-20240307688-A1 Bimodal vagus nerve stimulation to treat neurodegenerative disorders Pending 14-Mar-2023
EP-4655868-A2 Radio frequency power management and optimization Pending 25-Jan-2023
WO-2024158948-A2 Radio frequency power management and optimization Inactive 25-Jan-2023 G01R31/2822
To view SetPoint Medical’s complete patent history, request access »

SetPoint Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SetPoint Medical Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abbott Corporation Minority
Ally Bridge Group Growth/Expansion Minority
Elevage Medical Technologies Growth/Expansion Minority
Northwell Health Corporation Minority
SPRIG Equity Venture Capital Minority
You’re viewing 5 of 29 investors. Get the full list »

SetPoint Medical FAQs

  • When was SetPoint Medical founded?

    SetPoint Medical was founded in 2007.

  • Where is SetPoint Medical headquartered?

    SetPoint Medical is headquartered in Valencia, CA.

  • What is the size of SetPoint Medical?

    SetPoint Medical has 90 total employees.

  • What industry is SetPoint Medical in?

    SetPoint Medical’s primary industry is Therapeutic Devices.

  • Is SetPoint Medical a private or public company?

    SetPoint Medical is a Private company.

  • What is the current valuation of SetPoint Medical?

    The current valuation of SetPoint Medical is .

  • What is SetPoint Medical’s current revenue?

    The current revenue for SetPoint Medical is .

  • How much funding has SetPoint Medical raised over time?

    SetPoint Medical has raised $581M.

  • Who are SetPoint Medical’s investors?

    Abbott, Ally Bridge Group, Elevage Medical Technologies, Northwell Health, and SPRIG Equity are 5 of 29 investors who have invested in SetPoint Medical.

  • Who are SetPoint Medical’s competitors?

    Salvia BioElectronics, Mainstay Medical, Saluda Medical, Aleva Neurotherapeutics, and Curonix are some of the 13 competitors of SetPoint Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process